. The primary function of this RNA target, The Tat protein of the human immunodeficiency virustermed TAR (transactivating response region), is to target 1 (HIV-1) is a powerful transactivator of HIV gene expresTat to the promoter (Selby and Peterlin, 1990 ; Southgate sion and is required for replication of HIV (Arya et al., and Green, 1991) . We and others have shown that active 1985; . The mechanism of Tat transTat fusion proteins can be targeted upstream of a proactivation has been a subject of intense research and is moter and that Tat transactivation is dependent on the still somewhat controversial , partly bepresence of binding sites for cellular transcription faccause the HIV promoter directs the synthesis of high tors, most notably Sp1 (Kamine and Chinnadurai, 1992 ; levels of short RNA transcripts (Kao et al., 1987; Laspia Kamine et al., 1991; Southgate and Green, 1991) . Once et al., 1989; Ratnasabapathy et al., 1990; Toohey and targeted to the promoter, Tat might directly interact with Jones, 1989) . Therefore, Tat in principle could be acting Sp1 (Jeang et al., 1993) or basal transcription factors by a variety of mechanisms to increase the expression (Kashanchi et al., 1994) . of full-length RNA transcripts. Besides increasing tranTat transactivation of the HIV-1 LTR in transient expresscriptional initiation, Tat could increase the elongational sion assays shows a strong species tropism. In both efficiency of transcription or the antitermination of HIV rodent cells and avian cells the level of Tat transactivatranscripts. A unique feature of Tat transactivation is the tion is very low in comparison to that achieved in human use of a downstream promoter targeting mechanism cells (Madore and Cullen, 1993; Newstein et al., 1990) . (Muesing et al., 1987; Rosen et al., 1985) . Unlike convenLikewise, the Tat protein of equine infectious anemia tional transcriptional activators which are targeted upvirus (EIAV) is very active in equine cells but has only stream of a promoter via DNA binding sites, Tat is tarmarginal activity in human cells (Carroll et al., 1991) . geted to the HIV promoter by direct binding to the stemAnalysis of human-mouse hybrid cell lines has demonloop structure at the 5 end of the nascent RNA transtrated that only cell hybrids containing human chromoscripts initiated from the HIV promoter (Feng and Hol- some 12 restore high levels of Tat activity (Alonso et al., 1992; Hart et al., 1989; Newstein et al., 1990) . This spe-
The Tip nucleotide sequence reported in this article has been submitcies tropism can be overcome if a Tat-Rev fusion protein ted to the GenBank data base and assigned Accession No. U40989.
is targeted to the HIV promoter by the Rev RNA binding 1 To whom correspondence and reprint requests should be addressed.
site (Madore and Cullen, 1993) , indicating that the spe- 357 0042-6822/96 $18.00
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cies-specific factor might be involved in promoting Tat partial cDNA clone that encodes a protein that specifically interacts with the cysteine-rich region of the Tat interaction with TAR RNA.
Genetic experiments have supported the notion that activation domain. The encoded protein, Tip (Tat interactive protein), also binds to purified Tat in vitro. We have cellular factors are also necessary for Tat transactivation. These studies have used competition experiments beidentified the full-length cDNA for Tip and shown that overexpression of the encoded 60-kDa protein, Tip60, tween different Tat transactivators to inhibit Tat transactivation. In transient expression assays, the Tat protein of can augment Tat transactivation of the HIV-1 promoter fourfold in transient expression assays. EIAV could inhibit HIV-1 Tat-mediated transactivation of the HIV-1 LTR (Carrol et al., 1992; Madore and Cullen, 1993) . HIV-1 Tat can also inhibit transactivation by a Tat-MATERIALS AND METHODS Rev fusion protein targeted to the HIV promoter by the Yeast two-hybrid selection Rev RNA binding site (Madore and Cullen, 1993) . These competition experiments between different Tat transacti-A human B-cell cDNA library tagged with the Gal4 vators suggest that the activation domain of Tat interacts activation domain, cloned into the lambda phage cDNA with a cellular cofactor that is necessary for Tat transactiexpression vector system, l-ACT (Durfee et al., 1993), vation. was obtained from Steve Elledge. The construct, There have been several reported attempts to isolate pMA424-Tat1-31 (HIS3) (Ma and Ptashne, 1987) , contains cellular proteins that might serve as cofactors for Tat. A the coding sequences for the N-terminal 147-amino-acid cDNA clone was isolated from a lambda gt11 fusion li-DNA binding domain of GAL4 fused to coding sequences brary by utilizing a biotinylated Tat probe (Nelbock et al., for the N-terminal 31 amino acids of Tat. Yeast cells, 1990) . This protein, designated TBP1 (Tat binding protein strain GGY1::171, which contains an integrated copy of 1), is a 46-kDa nuclear protein that was initially described the GAL1-lacZ gene, were cotransformed with pMA424-as suppressing Tat transactivation in cotransfection exTat1-31 (HIS3) and pACT-cDNA (LEU2) by the LiAc techperiments (Nelbock et al., 1990 ). TBP1 appears to be a nique (Schiestl and Gietz, 1989) and clones containing member of a family of evolutionarily conserved genes both plasmids were selected on SC plates (minus leucine (Shibuya et al., 1992; Swaffield et al., 1992) . and minus histidine). After a 3-to 4-day incubation at In another approach, a 36,000-dalton cellular protein 30Њ, colonies were transferred to nitrocellulose filters, was isolated from human T-lymphocytes (molt3) by virtue permeablized on the filters by freeze thawing, and asof its binding to Tat . The cDNA for sayed for lacZ activity during 6-hr assays at 30Њ (Breeden this protein has recently been cloned and the encoded and Nasmyth, 1985). Positive blue colonies were picked protein, designated TAP (Tat-associated protein), has and transferred to His 0 and Leu 0 plates. The colonies been shown to associate with Tat in vivo and to have a (His / , Leu / ) on these secondary plates which gave blue cryptic transcriptional activation domain (Yu et al., 1995) .
color in the X-gal filter assay were picked and grown in Although a Gal-TAP fusion protein that is targeted up-SC medium. Plasmid DNA was isolated from one of these stream of a promoter-CAT construct can synergistically colonies (clone 10) and used to electroporate LeuB 0 interact with Tat to activate transcription, as Tat has been Escherichia coli (strain MH4) to recover the positive shown to do with other upstream promoter elements pACT-10 cDNA construct. This plasmid was used in two- (Berkhout et al., 1990; Kamine et al., 1991; hybrid assays with pMA424, pMA424-Tat1-31, and addiGreen, 1991), it has not been demonstrated that TAP is tional pMA424 constructs expressing a number of hetera specific Tat cofactor. ologous proteins to determine the Tat binding domain Another candidate Tat cofactor has recently been idenand the specificity of binding to Tat. The cDNA insert tified using the two-hybrid system in yeast (Fridell et was cut out from the plasmid by digestion with XhoI, al., 1995) . Although the protein encoded by the cDNA, cloned into Bluescript, and sequenced using the Sequedesignated HT2A, appears to specifically interact with nase method. the activation domain of the Tat proteins of HIV-1, HIV-2, and EIAV in two-hybrid systems in yeast and in mam-
In vitro binding assays malian cells it has not been shown to directly bind to Tat or to functionally interact with Tat in vivo or in vitro.
The cDNA insert of pACT-10 was PCR amplified with EcoRI and SalI termini and cloned, in frame, into the Likewise, a Tat-associated kinase activity has been shown to interact with the activation domains of the three EcoRI and SalI sites of the pET22b expression vector (Novagen). pET22b has an upstream consensus in frame lentivirus Tat proteins above (Hermann and Rice, 1995) , but its relationship to HT2A and its functional signifcance ATG and expresses cloned inserts under the control of the T7 RNA polymerase promoter. RNA was expressed in Tat transactivation have still not been established.
We have used the two-hybrid protein method in yeast using T7 RNA polymerase and translated with [
35 S]-methionine using a nuclease-treated rabbit reticulocyte as described by Fields and Song (1989) to identify a lysate in a linked transcription-translation system (TNT, L. K. Venkatesh), generating pCMVTIP60. pCMVTIP60 or the negative control parental expression vector, pCMV, Promega). To determine if the encoded protein could bind directly to Tat, in vitro binding assays were perwas transfected into HeLa cells via CaPO 4 -DNA coprecipitation along with pLTRCAT (Kamine et al., 1991) , formed between GST-Tat fusion proteins and radiolabeled Tip synthesized from pET-clone10. Tat coding sewhich expresses the CAT (chloramphenicol acetyltransferase) gene (Gorman et al., 1982) under the control of quences from the SF2 strain of HIV were fused in frame by PCR with the bacterial glutathione-S-transferase (GST) the HIV-1 promoter, and pCMVTAT. pCMVTAT expresses the HIV-1 (SF2 strain) Tat gene under the control of the gene in the pGex-2T expression vector (Pharmacia). GST-Tat recombinant fusion proteins were induced with CMV immediate early promoter and was constructed by inserting the Tat gene and poly(A) addition signal (BlgII IPTG and isolated on glutathione-Sepharose beads as described by Kaelin et al. (1991) . Binding assays were to SalI) from pTat (Peterlin et al., 1986) into pgTat (Malim et al., 1989) . HeLa cells (3 1 10 5 ) were plated on 60-mm 2 performed in binding buffer containing 20 mM HEPES, pH 7.7, 50 mM KCl, 2.5 mM MgCl 2 , 10% glycerol, and 1 culture dishes and cotransfected with 5 mg of pLTRCAT and 0, 2, 5, or 12 ng of pCMVTAT and 0, 1, or 2 mg of mM DTT. After 1-hr binding assays at 4Њ, the GST-Tat complexes bound to the glutathione-Sepharose beads pCMVTIP60. In each transfection, the amount of pCMV expression vector was adjusted to 2 mg with the parental were washed in RIPA buffer and bound complexes eluted by boiling in Laemmli sample buffer then loaded on an expression vector, pCMV. 10% PAGE-SDS gel.
RESULTS Lambda library screening for full-length Tip
Identification of a cDNA clone for a cellular protein A lambda gt11 cDNA library from the HUT-78 T-cell that specifically interacts with Tat in yeast line (5 stretch library, Clontech, Inc.) was screened with
In the two-hybrid selection system that we have used a labeled PCR probe using specific primers from the (Fields and Song, 1989 ) a target plasmid expressing the clone 10 sequence. The 5 end of the PCR primers were DNA binding domain of Gal4 fused to the target seat positions 245 and 595 from the 5 end of the yeast quence of interest is used to target the fusion protein via clone 10, generating a 350-bp probe. Phages from posithe Gal4 DNA binding sites of the UAS G yeast regulatory tive plaques were purified and the cDNA insert was region upstream of the E. coli lacZ reporter gene which cloned into a Bluescript (KS) vector and sequenced using is under the Gal1 promoter. Cotransfection of a second the Sequenase method. The clone 10 cDNA sequences construct that contains the activation domain of Gal4 were recombined with the lambda gt11 library cDNA sefused to sequences from a cDNA library can activate quences in the Bluescript (KS) vector via an internal EagI lacZ expression if Tat and the sequences encoded by site to reconstruct the full-length cDNA for TIP60. Sense the cDNA can interact, resulting in the production of blue RNA was transcribed with T3 RNA polymerase and transcolonies. Activation of lacZ activity in transfected clones lated in a linked transcription-translation system (Procan be identified as blue colonies on X-gal filter assays. mega).
We reasoned that the N-terminal 48 amino acids of Tat which constitute the activation region of Tat would Northern blot analysis be a suitable target to search for proteins that interact Four micrograms of poly(A) / RNA (Fast Track, Inwith Tat. This activation domain of Tat functions automavitrogen, San Diego) from the indicated cell line was run mously and activates transcription when targeted to a on a 1% agarose-formaldehyde gel and transferred to promoter via a heterlogous DNA binding domain (Kamine nitrocellulose. Molecular weight standards were from an et al., 1991; Southgate and Green, 1991) . Since the full RNA ladder (Bethesda Research Labs). The blot was first activation domain of Tat activates the GAL1 promoter probed with 2.5 1 10 7 dpm of an antisense 32 P-labeled in yeast (Subramanian et al., 1994) (Table 1) we used riboprobe against the clone 10 cDNA. The antisense subregions of the Tat activation domain as targets in the probe was generated from a Bluescript vector containing two-hybrid system. pMA424-Tat1-31, which contains the the clone 10 insert using T3 RNA polymerase. Blot was N-terminal 31 amino acids of Tat, was found to be incapathen stripped and reprobed with a 1 1 10 7 dpm of a 32 Pble of activating lacZ activity by itself (Subramanian et labeled random primed probe against a g-actin molecual., 1994) (Table 1) ; however, when pMA424-Tat1-31 was lar clone.
used to screen a cDNA library fused to the activation domain of Gal4 (pACT-cDNA) a number of positive blue Transfections colonies were detected against the background of white colonies in the X-gal filter assay. These blue colonies The complete Tip 1.9-kb cDNA from pKSTIP60 was cloned downstream of the CMV immediate early prowere picked and after a secondary X-gal screening on His 0 and Leu 0 selective plates, the pACT-cDNA plasmid moter in the pCMVT7HA expression vector (supplied by Note. The indicated yeast strain was transformed with the indicated target plasmid and either the control construct, pACT, which expresses readily assessed (Table 1 ). In cells expressing the Tat1-only the Gal4 activation domain or pACT-10, which was recovered from 48(41) target and clone pACT-10 there was much more an initial pACT-cDNA library screen in the yeast two-hybrid system lacZ expression than in cells expressing Tat1-48(41) and with pMA424-Tat1-31. lacZ activity was either detected by X-gal filter the control vector DNA (pACT) ( Table 1) . These results assays by blue colony formation or quantitated by b-galactosidase and the in vitro binding data (see below) indicate that activity in liquid culture medium as described (Subramanian et al., 1994) . Minus indicates colonies remained white after X-gal staining for the protein coded by clone pACT-10 efficiently interacts more than 12 hr; //// indicates intense color development within 1 with the full-length Tat activation domain but that mutahr which was greater than 10-fold faster than color development by tions of the core region do not affect Tip binding to Tat.
The conserved cysteine-rich domain of Tat is involved in interaction with pACT-10 DNA was isolated from each clone. This DNA was used Mutation of either of the two cysteine residues at posito transform the yeast indicator strain with either the tions 22 or 30 in the cysteine-rich domain of Tat elimicontrol construct pMA424 or pMA424-Tat1-31. One of nates interaction of pACT-10 with pMA424-Tat1-31. Subthe clones, clone 10, designated pACT-10, produced an stitution of a glycine for the cysteine at position 22 of intense blue color selectively with pMA424-Tat1-31 but Tat (pMA424-Tat1-31(22)) or position 30 (pMA424-Tat1-not pMA424 (Table 1) . 31(30)) gave only white colonies in the two-hybrid assay with pACT-10 (Table 1) . Therefore, the essential cysteine The pACT-10 clone specifically interacts with Tat in region of Tat appears to be part of the binding domain the two-hybrid system for interaction with clone 10. This is an important demonstration because mutation of either of these two cyslacZ expression was not activated when a number of heterologous proteins were used in place of Tat coding teines in native Tat abolishes Tat activity. The correlation of Tat activity with the ability to bind to the interactive sequences in pMA424. The two-hybrid assays with pACT-10 and the individual pMA424 constructs indicated yeast clone strongly suggests that interaction of pACT-10 to Tat is an important function for Tat activity. that the HIV-1 Rev protein, the HTLV-1 Rex and Tax regulatory proteins, as well as the adenovirus E1B 19K could cDNA for Tip not substitute for Tat and activate lacZ expression in the two-hybrid system (Table 1 ). In addition, DNA coding for
The clone 10 cDNA is 1581 nucleotides long and contains a long open reading frame that starts at the 5 end Tat amino acids 31-48 (pMA424-Tat31-48) was also neg-believed to function in silencing the HMR locus (Genbank Accession No. U14548). The Tip sequence also has several regions suggesting potential phosphorylation sites. The most suggestive site is an Arg-Lys-Asn-Lys-Ser amino acid motif between nucleotides 890 and 904 of the Tip cDNA sequence (Fig. 1A) . The two basic residues followed by two intervening residues and then a serine are very characteristic of a cAMP-dependent protein kinase phosphorylation site (Czernik, 1991) , suggesting that Tip might be a phosphoprotein. We have identified the 5 end of the cDNA for Tip by two independent lambda gt11 cDNA library screenings: a PMA-activated HUT-78 T-cell library and a Raji B-cell library (both 5 stretch, Clontech, Inc.) using specific primers from the clone 10 sequence. The 5 end of the full-length clone extends 364 nucleotides beyond the 5 end of clone 10, giving a total composite cDNA length of 1945 nucleotides. The sequence and structure of the full-length cDNA for Tip is shown in Fig. 1 .
The composite 1.9-kb full-length cDNA for Tip was cloned into the Bluescript (KS) vector via an internal EagI site to generate pKSTIP60. RNA was transcribed with T3 RNA polymerase and translated in a linked transcription-translation system (Promega). A 60,000-dalton [ 35 S]methionine-labeled protein was synthesized with pKSTIP60 ( Fig. 2, lane 2) that was not detected with the KS vector without insert pKS (Fig. 2, lane 1) . The level of expression of Tip60 from pKSTIP60 is very much lower than that achieved with the clone 10 cDNA fused to an in-frame heterologous ATG in the pET expression vector system (compare Fig. 2 to Fig. 4B, lane 1) . Interestingly, there is no in-frame ATG within the first 600 nucleotides of the Tip cDNA sequence. There is, however, an inframe CTG triplet in a favorable Kozak context at the start of the cDNA (nucleotides 65-67); this is the only in-frame CTG in a favorable Kozak context within the first 600 of the clone and extends for 1146 nucleotides. The size of the inferred protein product is 383 amino acids with a molecular mass of 44,000 daltons (Fig. 1B) . We have designated this encoded amino acid sequence Tip, for Tat of Sas2p in yeast has not been documented but it is amounts of the 2-kb g-actin mRNA (Fig. 3B) . These data suggest that Tip is expressed in roughly equivalent amounts in various cell types.
Tip binds to Tat in vitro
To extend and confirm our results on Tip and Tat interaction in yeast, we examined if Tip could directly bind to Tat in vitro. In vitro binding assays were performed between GST-Tat fusion proteins and the radiolabeled Tip protein encoded by clone 10 and inserted into pET (pETclone10). SDS-PAGE analysis of the [ (Fig. 4A, lane 1) . This protein represents the partial probed with (A) 2.5 1 10 7 dpm of an antisense 32 P-labeled riboprobe against the clone 10 cDNA. The antisense probe was generated from Tip protein encoded by the cDNA recovered in the twoa Bluescript vector containing the clone 10 insert using T3 RNA polyhybrid assay in yeast. Tip showed no binding to a control merase. The autoradiogram was exposed for 7 days. Molecular weight GST protein (Fig. 4A, lane 2) (Fig. 4B, lane 3) . Tip et al., 1988,) . We have also isolated Tip genomic clones and find that there is no potential ATG initiation codon before termination codons upstream of the 5 end of the Tip cDNA. In addition, we have determined that the genomic sequences within 250 nucleotides of 5 end of the Tip cDNA contain a transcriptional promoter when cloned into the promoterless CAT construct pCAT3M (data not shown). This promoter does not contain a TATA box but has a number of consensus binding sites for transcription factors, including Sp1 (data not shown). These data together with the 1.9-kb size of Tip cellular mRNA (see below) suggest that we have isolated the full-length cDNA for Tip and that an ATG triplet does not specify an initiator methionine for the 60,000-dalton Tip (Fig. 3 ). An antisense 32 P-labeled riboprobe against P-labeled probe against g-actin mRNA conlabeled luciferase (lane 9) showed no binding to either GST or GSTTat1-48 (lanes 7 and 8, respectively) in these assays.
firmed that each of the preparations contained equivalent also bound quite strongly to GST-Tat (D6), a mutant lacking the N-terminal 6 amino acids of Tat (Fig. 4B,  lane 5 ), but showed a definite reduced binding to GSTTat(22) , which has a single cysteine to serine point mutation at residue 22 of Tat (Fig. 4B, lane 6) . The reduction in binding of to Tip was much less drastic than the absolute reduction in lacZ activation with the Tat(22) mutation in the two-hybrid assay, suggesting that the in vivo assay is more sensitive to Tat mutant phenotype than the in vitro binding assay. Under these same assay conditions, the [ 35 S]methionine-luciferase negative control (Fig. 4B, lane 9) did not bind to either GST (Fig. 4B, lane 7) or GST-Tat1-48 (Fig. 4B, lane 8) .
Overexpression of Tip in transient expression assays augments Tat transactivation of the HIV-1 promoter pCMVTIP60 did not increase the basal level of expression of the HIV-1 LTR (Fig. 5A) , nor did pCMVTIP60 activate the heterlogous Rous sarcoma LTR linked to the CAT gene in transient expression assays (Fig. 5B) . Likewise, overexpression of Tip did not augment activity of EIAV Tat (which lacks a cysteine-rich region) on the EIAV promoter in transient CAT assays (data not shown). However, HIV-1 Tat activity, at 2 ng of pCMVTAT, was increased fourfold with 2 mg of pCMVTIP60. With higher amounts of pCMVTAT, transactivation of CAT activity in- assays results in a fourfold augmentation of Tat transacti-DISCUSSION vation of the HIV-1 promoter in HeLa cells. This augmentation of Tat transactivation is specific for Tat transactiva-A number of genetic and biochemical observations have suggested that cellular factors interact with Tat to tion since neither the basal activity of the HIV promoter in the absence of Tat or the activity of the RSV promoter regulate HIV gene expression (Alonso et al., 1992; Carroll et al., 1991 Carroll et al., , 1992 Hart et al., 1989; Madore and Cullen, is increased by overexpression of Tip60. This specific augmentation of Tat transactivation by Tip60 overex-1993; Newstein et al., 1990) . The identification of cellular proteins that can functionally interact with Tat would be pression implies that the specific binding of Tip60 to Tat that is observed in yeast and in vitro might be an imof great importance in understanding the mechanism of Tat transactivation. Using the two-hybrid system in yeast portant feature for efficient Tat transactivation of HIV gene expression. we have been able to isolate a cDNA for a protein termed Tip that interacts with the N-terminal 31 amino acids of Interaction of Tat1-31 with Tip in the two-hybrid system could be prevented by single amino acid substitutions HIV Tat. This in vivo interaction is specific since coding sequences for heterologous proteins cannot substitute of glycine for cysteine at either position 22 or 30 in the conserved cysteine-rich region of Tat (amino acids 18-for Tat1-31 and single amino acid substitutions in the activation domain of Tat abolish interaction with Tip. Tip 37). Tip did not interact with the core region of the Tat activation domain alone, nor did single amino acid subhas also been shown to specifically bind to Tat in vitro.
Overexpression of Tip60 in transient expression stitutions in the core region block Tip interaction with Tat. Therefore, it would appear that only the cysteinetained at high levels or be tightly regulated. It is also interesting to note that the greatest augmentation of Tat rich region of the Tat activation domain is involved in binding Tip. The cysteine-rich domain is one of three transactivation by Tip occurs when the amount of Tat expression construct is very low in the transfection essential regions of HIV-1 Tat (Garcia et al., 1988; Kuppuswamy et al., 1989) . The other required regions are assays. This might be especially relevant in some chronically infected HIV cell lines like the monocyte cell line, the 9-amino-acid arginine-rich basic region which is required for nuclear localization and for binding to TAR U1, in which low levels of Tat activity appear to be the limiting factor for the induction of HIV replication (Cannon RNA and the 10-amino-acid core region. The function the core region is unknown. In the case of the cysteine-rich et al., 1994) . In principal, up-regulation of Tip levels in chronically or latently infected cells could be a factor in region, six of the seven cysteine residues are absolutely required for HIV-1 Tat activity (Kuppuswamy et al., 1989) .
the induction of HIV replication in these cells. Although the cysteine-rich region is known to be essential for the activity of Tat it might not be part of an activa-ACKNOWLEDGMENTS tion domain per se but, as our results suggest, might be 
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transcription, suggesting that the Tat proteins from HIV-1, HIV-2, and EIAV interact with a common cofactor (Carroll et al., 1992; Madore and Cullen, 1993) . However, REFERENCES these data do not rule out that the Tat proteins from Alonso, A., Derse, D., and Peterlin, B. M. (1992) . Human chromosome different lentiviruses also interact with specific additional 12 is required for optimal interactions between tat and tar of human cofactors. This is implied by the fact that the cysteine- al., 1989) . In addition, Tat has been implicated in the Breeden, L., and Nasmyth, K. (1985) . Regulation of the yeast HO gene.
activation (Buonaguro et al., 1992) and repression (HowCold Spring Harbor Symp. Quant. Biol. 50, 643-650. Cannon, P., Kim, S.-H., Ulich, C., and Kim, S. (1994) . Analysis of tat croft et al., 1993) of a number of different cellular genes function in human immunodeficiency virus type 1-infected low-levelinvolved in immunoregulation. Under some conditions expression cell lines U1 and ACH-2. J. Virol. 68, 1993 Virol. 68, -1997 Tat can also stimulate the antigen-dependent prolifera- Carroll, R., and Derse, D. (1993) . Translation of equine infectious anemia tion of T-lymphocytes (Viscidi et al., 1989) and can act virus bicistronic tat-rev mRNA requires leaky ribosome scanning of as a growth factor for Kaposi sarcoma cells in culture the tat ctg initiation codon. J. Virol. 67, 1433 -1440 . Carroll, R., Martarano, L., and Derse, D. (1991 . Identification of lentivirus (Barillari et al., 1993) . portant for Tat activity, intracellular Tip might be main-
